Affymax (AFFY) wins approval for its drug to treat anemic kidney patients -Bloomberg
- Top 10 News for 07/21 - 07/25: In the Thick of Earnings; M&A Ramps Up; Where's the Homes?
- Goldman's GOAL Cuts Equities to Neutral, Corporate Credit to Underweight
- Amazon.com, Inc. (AMZN) Posts Q2 Loss of 24c/Share
- IBM (IBM) Rejects Offer for Chip-Making Unit - Bloomberg
- Containerboard Stocks Could Revalue Up to 100% Under MLP Structures, Perry Capital Says (IP) (KS) (RKT)
Affymax (Nasdaq: AFFY) wins approval for its drug to treat anemic kidney patients
You May Also Be Interested In
- Organovo (ONVO), Janssen (JNJ) Enter Agreement for 3D Bio-Printer Tissue for Drug Discovery
- BlackBerry (BBRY) Pops Higher on Chatter
- WPCS (WPCS) Stock Gains; Subsidiary Launches Digital Currency Product
Create E-mail Alert Related CategoriesFDA, Momentum Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!